OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023

Stock Information for Augmedix Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Augmedix Inc.

OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report
OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results
OptimizeRx Named America's Fastest-Growing Company for Fifth Year in a Row
OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET
OptimizeRx Powers Walmart's 'Specialty Pharmacies of the Community' Outreach Effort
OptimizeRx to Participate in Upcoming Investor Conferences
OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.